Vardenafil Tablet, Film Coated
Product Images NDC 71610-477

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Vardenafil (NDC 71610-477). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Vardenafil Tablets (11dc6238 F3ca 42d3 9146 D7e01588a3cb 01)

Chemical structure diagram of Vardenafil, labeled with additional components indicating hydrochloride and trihydrate forms.*

FDA Label Image

Vardenafil Tablets (11dc6238 F3ca 42d3 9146 D7e01588a3cb 02)

Three line graphs showing mean maximal changes in systolic blood pressure (mmHg), diastolic blood pressure (mmHg), and heart rate (bpm) over time points 24h, 8h, 4h, and 1h pre-vardenafil treatment compared to pre-NTG baseline. Each graph includes error bars indicating variability.*

FDA Label Image

Vardenafil Tablets (11dc6238 F3ca 42d3 9146 D7e01588a3cb 03)

A line chart illustrating mean change in mmHg over six hours comparing placebo and vardenafil 5 mg under simultaneous and 6-hour separation conditions. The x-axis represents time in hours, and the y-axis shows mean blood pressure change. Four data series are displayed using different markers for placebo and vardenafil with different administration timings.*

FDA Label Image

Vardenafil Tablets (11dc6238 F3ca 42d3 9146 D7e01588a3cb 04)

A line graph showing mean change in mmHg on the Y-axis versus time in hours on the X-axis, comparing placebo and Vardenafil 5 mg under simultaneous and 6-hour separation conditions. Four distinct lines represent each group, illustrating differences in blood pressure change over a 6-hour period.*

FDA Label Image

Vardenafil Tablets (11dc6238 F3ca 42d3 9146 D7e01588a3cb 05)

A line graph depicting mean change in mmHg versus time in hours for placebo and vardenafil at 10 mg and 20 mg doses. The graph shows four lines representing placebo (stage 1 and 2) and vardenafil 10 mg and 20 mg over a 6-hour period, highlighting the differences in mean change over time.*

FDA Label Image

Vardenafil Tablets (11dc6238 F3ca 42d3 9146 D7e01588a3cb 06)

A line graph depicting mean change in mmHg blood pressure (y-axis) over time in hours (x-axis) for four groups: Placebo Stage 1, Placebo Stage 2, Vardenafil 5 mg, and Vardenafil 10 mg. The graph tracks blood pressure changes over a 6-hour period, showing trends for placebo and two doses of Vardenafil.*

FDA Label Image

Vardenafil Tablets (11dc6238 F3ca 42d3 9146 D7e01588a3cb 07)

A line graph titled 'TERAZOSIN' depicting mean change in mmHg on the y-axis against time in hours on the x-axis. It compares placebo, 10 mg vardenafil, and 20 mg vardenafil effects under two conditions: 6-hour separation and simultaneous administration. Each condition is represented with distinct markers and line styles showing trends over 6 hours.*

FDA Label Image

Vardenafil Tablets (11dc6238 F3ca 42d3 9146 D7e01588a3cb 08)

A line graph titled 'Tamsulosin' showing mean change in mmHg over time (hours). It compares placebo and Vardenafil doses (10 mg and 20 mg) with two conditions: 6-hour separation and simultaneous administration. The y-axis represents mean change in blood pressure, and the x-axis represents time from 0 to 6 hours.*

FDA Label Image

Vardenafil Tablets (11dc6238 F3ca 42d3 9146 D7e01588a3cb 09)

A line graph depicting plasma concentration (µg/L) of Vardenafil over a 24-hour period. The x-axis represents time in hours (0 to 24), while the y-axis shows plasma concentration with data points indicating concentration levels peaking early and declining over time, including error bars for variability.*

FDA Label Image

Bottle Label 20 mg (71610 0477 02)

Label for Vardenafil Hydrochloride 20 mg film-coated tablets, oral route. The label shows the NDC number 71610-0477-02, manufacturer as Cadila Healthcare Ltd., Ahmedabad, India, and labeler as Aphena Pharma Solutions - Tennessee, LLC, Cookeville, TN 38506. The packaging contains 2 tablets with storage instructions and a barcode.*

FDA Label Image

Aphena Pharma Solutions (TN)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.